References

Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study

10.1016/j.jacc.2020.11.010 · 2020 · External reference

Health functions and related molecular mechanisms of tea components: an update review

10.3390/ijms20246196 · 2019 · External reference

Impact of oxidative stress on the heart and vasculature: part 2 of a 3-part series

10.1016/j.jacc.2017.05.035 · 2017 · External reference

Cellular defensive mechanisms of tea polyphenols: structure-activity relationship

10.3390/ijms22179109 · 2021 · External reference

EGCG Protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling

10.1152/japplphysiol.00879.2009 · 2010 · External reference

Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase

10.1002/mnfr.201400699 · 2015 · External reference

Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis

10.1371/journal.pone.0016974 · 2011 · External reference

Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis

10.1016/j.ijcard.2012.09.047 · 2013 · External reference

Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials

10.1038/srep06251 · 2014 · External reference

Theaflavin: a natural candidate to restrain thrombosis

10.1039/d2fo00152g · 2022 · External reference

Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity

10.1097/fjc.0b013e31815ab4b6 · 2008 · External reference

Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment

10.3904/kjim.2016.228 · 2018 · External reference

Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF-β1/Smad3 signaling pathway

10.3892/mmr.2018.8825 · 2018 · External reference

Theaflavin-3,3'-digallate protects against myocardial ischemia/reperfusion injury and hypoxia/reoxygenation injury by activating the PI3 K/akt/mTOR pathway

10.1007/s10735-025-10453-z · 2025 · External reference

Gut Microbiota metabolites and risk of Major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies

10.1161/jaha.116.004947 · 2017 · External reference

Theabrownin from pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism

10.1038/s41467-019-12896-x · 2019 · External reference

Theabrownins from dark tea: formation, gut microbiota-mediated biotransformation, health benefits, and potential in functional food applications

10.1039/d5fo02046h · 2025 · External reference

Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability

2002 · External reference

Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: the China-PAR project

10.1177/2047487319894685 · 2020 · External reference

Tea consumption and all-cause and cause-specific mortality in the UK biobank: a prospective cohort study

10.7326/m22-0041 · 2022 · External reference

Green tea and coffee consumption and all-cause mortality among persons with and without stroke or myocardial infarction

10.1161/strokeaha.120.032273 · 2021 · External reference

Low-dose green tea intake reduces incidence of atrial fibrillation in a Chinese population

10.18632/oncotarget.12243 · 2016 · External reference

No causal association between tea consumption and 7 cardiovascular disorders: a two-sample Mendelian randomization study

10.3389/fgene.2022.989772 · 2022 · External reference

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis

10.1016/j.jacc.2010.05.034 · 2010 · External reference

Effects of tea consumption on metabolic syndrome: a systematic review and meta-analysis of randomized clinical trials

10.1002/ptr.6731 · 2020 · External reference

The association between green tea intake and metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials

10.1016/j.clinthera.2025.09.011 · 2025 · External reference

Association between habitual tea consumption and metabolic syndrome and its components among Chinese adults aged 18∼59 years: based on China nutrition and health surveillance 2015–2017

10.3390/nu14173502 · 2022 · External reference

Habitual tea consumption increases the incidence of metabolic syndrome in middle-aged and older individuals

10.3390/nu15061448 · 2023 · External reference

Dose-Response relation between tea consumption and risk of cardiovascular disease and all-cause mortality: a systematic review and meta-analysis of population-based studies

10.1093/advances/nmaa010 · 2020 · External reference

Tea consumption and risk of all-cause, cardiovascular disease, and cancer mortality: a meta-analysis of thirty-eight prospective cohort data sets

10.4178/epih.e2024056 · 2024 · External reference

Coffee and tea consumption and cardiovascular disease and all-cause and cause-specific mortality in individuals with diabetes mellitus: a meta-analysis of prospective observational studies

10.3389/fnut.2025.1570644 · 2025 · External reference

Phytochemical profile of differently processed tea: a review

10.1111/1750-3841.16137 · 2022 · External reference

Factors affecting the levels of tea polyphenols and caffeine in tea leaves

10.1021/jf021066b · 2003 · External reference

Scientific opinion on the safety of green tea catechins

10.2903/j.efsa.2018.5239 · 2018 · External reference

The effect of tea on iron absorption

10.1136/gut.16.3.193 · 1975 · External reference

Effects of green tea extract on atorvastatin pharmacokinetics in healthy volunteers

10.1007/s13318-020-00608-6 · 2020 · External reference

Probable antagonism of warfarin by green tea

10.1345/aph.18238 · 1999 · External reference

Caffeine and cardiovascular disease: a scientific statement from the American Heart Association

10.1161/cir.0000000000001454 · 2026 · External reference

Prevalence of brick tea-type fluorosis in the Tibet autonomous region

10.2188/jea.je20150037 · 2016 · External reference

2021 ESC guidelines on cardiovascular disease prevention in clinical practice

10.1093/eurheartj/ehab484 · 2021 · External reference

2026 Dietary guidance to improve cardiovascular health: a scientific statement from the American Heart Association

10.1161/cir.0000000000001435 · 2026 · External reference